ELISA tests will lead poultry diagnostic testing sales through 2035 with 36.8% share of the test segment in 2025. Avian influenza held 29.5% share of the disease segment and North America accounted for 35.6% share of the regional segment. The market was valued at USD 1.0 billion in 2025.